Inflammatory Bowel Disease Models
We offer an extensive panel of inflammatory bowel disease models in mice and rats, including genetically modified, chemically induced, and...
Continue Reading
We offer an extensive panel of inflammatory bowel disease models in mice and rats, including genetically modified, chemically induced, and...
Continue Reading
Drug Discovery Chemistry Conference 2023 WuXi AppTec has developed technologies to facilitate RNA small molecule screening, an exciting frontier in...
Continue Reading
Drug Discovery Chemistry Conference 2023 Powerful biophysical and structural biology tools enable the study of large numbers of covalent fragments...
Continue Reading
Drug Discovery Chemistry Conference 2023 DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel...
Continue Reading
Our comprehensive panel of orthotopic and metastasis syngeneic models includes: 17 orthotopic/disseminated models covering 10 cancer types; Organ-based orthotopic models...
Continue Reading
DLL3 related lung cancer PDX models, validated by RNA-Seq and IHC staining
Continue Reading
c-Met is a receptor tyrosine kinase, a/k/a hepatocyte growth factor receptor (HGFR). As a type of proto-oncogene, c-Met overexpression, amplification...
Continue Reading
Discover our comprehensive platform of CDX and PDX tumor models, carrying BRAF mutations across multiple cancer types: 18 CDX models...
Continue Reading
Leverage our extensive panel of rat xenograft and syngeneic tumor models. Advantages for using rats in preclinical efficacy studies compared...
Continue Reading